Loading...
Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis, and cell cycle arrest in cancer cells. Recently, their use has been clinically validated in cancer patients resultin...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
e-Century Publishing Corporation
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3056563/ https://ncbi.nlm.nih.gov/pubmed/21416059 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|